Laccase as an efficacious approach to remove anticancer drugs: A study of doxorubicin degradation, kinetic parameters, and toxicity assessment.
Anticancer drugs
Antineoplastic drugs
Enzymatic degradation
Oxidoreductases
Journal
Journal of hazardous materials
ISSN: 1873-3336
Titre abrégé: J Hazard Mater
Pays: Netherlands
ID NLM: 9422688
Informations de publication
Date de publication:
05 05 2021
05 05 2021
Historique:
received:
18
05
2020
revised:
05
11
2020
accepted:
06
11
2020
pubmed:
27
11
2020
medline:
1
6
2021
entrez:
26
11
2020
Statut:
ppublish
Résumé
The degradation of an anticancer drug by laccase was investigated for the first time, bringing a new approach to treat these hazardous substances through the direct enzymatic application. Degradations of doxorubicin by laccase were performed in different enzymatic concentrations, pH values and temperatures through kinetic studies. The highest enzymatic degradation of doxorubicin was achieved at pH 7 and 30 ºC, which resembles effluent characteristics from wastewater treatment plants. Assays were carried out in different doxorubicin concentrations to comprehend the enzymatic kinetics of degradation. Michaelis-Menten kinetic parameters obtained were maximum velocity obtained (V
Identifiants
pubmed: 33239208
pii: S0304-3894(20)32510-3
doi: 10.1016/j.jhazmat.2020.124520
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Doxorubicin
80168379AG
Laccase
EC 1.10.3.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
124520Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.